Login with ORCID

association

Full identifier: http://purl.org/np/RAH-8nVPXuLdCWTXbyVdxkCUyTfbrkvlBRi50_OKcfdvM#association

Assigned to 1 class:

Minted in Nanopublication

 RAH-8nVPXu comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAH-8nVPXu... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal)
(xsd:dateTime)
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAH-8nVPXu... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAH-8nVPXu... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAH-8nVPXu... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC...
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Orphenadrine citrate extended-release tablets are contraindicated in patients with glaucoma, pyloric or duodenal obstruction, stenosing peptic ulcers, prostatic hypertrophy or obstruction of the bladder neck, cardio-spasm (mega-esophagus) and myasthenia gravis. Orphenadrine citrate tablets are contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T12:33:31.025Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)